Drug discovery and development of novel therapeutics for bone and joint diseases

Arcarios BV
Tolleiv Trimborn, CEO
's-Gravendijkwal 230 - Room 1914 3015 CE Rotterdam, The Netherlands T: + 31 (0)6 2054 3382

Novel platform for the generation of human monoclonal antibodies

arGEN-X BV
Tim Van Hauwermeiren, CEO
Dr. Molewaterplein 50
3015 GE Rotterdam, The Nederlands
T: +31 6 122 85 257

Biopharmaceutical R&D contract organization and developer of anti-inflammatory and anti-cancer drugs

Bioceros BV
Bram Bout, CEO
Yalelaan 46
3584 CM Utrecht, The Netherlands
T: +31 (0)30 - 2537910

Commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in next generation sequencing and other applications.

Fred Dom, CEO
Wassenaarseweg 72
2333 AL Leiden, The Netherlands
T: +31 71 332 22 00

 

Biomaterials company developing resorbable medical implants based on proprietary polymers

Medisse BV
Sandra de Vos, CEO
Barchman Wuytierslaan 154
3818 LM Amersfoort, The Netherlands
T: + 31 (0)650 281 838

Developer of vaccines based on proprietary adjuvant and carrier technology

Mucosis BV
Govert Schouten, CEO
L. J. Zielstraweg 1
9713 GX Groningen, The Netherlands
T: +31 (0)50 3612112

Service Lab for molecular diagnostics and research in biomarkers for GU cancer

NovioGendix BV
Bastiaan J. de Leeuw, CEO
Geert Grooteplein-Zuid 10
6525 GA Nijmegen, The Netherlands
T: + 31 (0)24 3279054

 
Unique osteoinductive materials for clinical application in bone regenerative surgery